Key result
A 52-year-old man with rheumatoid arthritis on methotrexate developed large pleural and pericardial effusions that were determined to be secondary to his autoimmune disease rather than drug toxicity.
Why the study?
Differentiating pleuropulmonary and pericardial complications of rheumatoid arthritis from side effects of immunosuppressive therapy presents significant diagnostic challenges.
Case Report (n=1)
This case highlights the diagnostic challenges of differentiating pleuropulmonary and pericardial complications of rheumatoid arthritis from side effects of immunosuppressive therapy.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to RA effusion diagnostic pitfalls on therapy; leaves open abatacept's causal role.
Rheumatoid arthritis (RA) is the most common multisystemic autoimmune inflammatory joint disorder, affecting nearly 1.3 million adults in the US. RA has high economic and social burdens. Functional disability may arise in RA from the characteristic chronic progressive inflammation and the erosion of multiple joints and cartilage damage. Systemic manifestations of RA include rheumatoid nodules, pleuropulmonary complications, pericarditis, rheumatoid vasculitis, Felty's syndrome (the rare triad of rheumatoid arthritis, splenomegaly, and neutropenia), amyloidosis, and neurological complications. We present the diagnostic challenges of differentiating pleuropulmonary and pericardial complications of rheumatoid arthritis from side effects of therapy (rheumatoid pleural and pericardial effusions vs immune suppression associated side effects and infections). We use the Naranjo score to facilitate this decision-making process. A 52-year-old man with a history of RA, chronic small right pleural effusion, and hypertension on long-term oral methotrexate and corticosteroid therapy presented to the emergency room after 1 week of worsening respiratory symptoms. A chest radiograph demonstrated a large pleural effusion and pneumonia. Intravenous methylprednisolone and antibiotics were administered. A video-assisted thoracoscopic procedure was performed, chest tubes were inserted, and abatacept was eventually initiated as adjunctive therapy to methotrexate and corticosteroid therapy for the rheumatoid arthritis and lung condition. Abatacept is an immunosuppressive fusion protein composed of the Fc region of immunoglobulin G1 fused to the extracellular domain of cytotoxic T-lymphocyte-associated protein 4, which interferes with the immune activity of T cells.
No takes yet. Share an insight, caveat, or question.
Whitfield et al. (2020) conducted a case report in Rheumatoid arthritis with pleural and pericardial effusions (n=1). Methotrexate was evaluated on Etiology and resolution of effusions. A 52-year-old man with rheumatoid arthritis on methotrexate developed large pleural and pericardial effusions that were determined to be secondary to his autoimmune disease rather than drug toxicity.
Synapse has enriched 10 related papers. Consider them for comparative context: